← FDA DRUG APPROVALS

FDA ANDA · ANDA211750

HYDROCORTISONE VALERATE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA211750
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-14
LATEST ACTION
2018-12-14
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued

Products

HYDROCORTISONE VALERATEDiscontinued
HYDROCORTISONE VALERATE 0.2% · OINTMENT · TOPICAL

Approval history

2018-12-14UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →